|
|
SFX by Ex Libris Inc. |
Contains information about title and source of a journal
Naslov: |
152TiP Trial in progress: Imatinib to convert triple-negative breast cancer into estrogen receptor (ER)-positive breast cancer - A window of opportunity trial |
Vir: |
|
|
|
|
List of services to meet your request
Contains list of services for current record
Basic services |
|
|
© 2024 SFX by Ex Libris Inc. | Piškotki
CrossRef Omogočeno
|